Systemic protein therapy for recessive dystrophic epidermolysis bullosa: How far are we from clinical translation?

Journal of Investigative Dermatology

Volumn 133, Issue 7, 2013, Pages 1719-1721

  Hovnanian, Alain ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBRIL; COLLAGEN TYPE 7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL THERAPY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE THERAPY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84879354088     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.137     Document Type: Note

References (13)

1. Desnick RJ, Schuchman EH (2012) Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Ann Rev Genom Hum Genet 13:307-35
2. Fine JD, Eady RA, Bauer EA et al. (2008) The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58: 931-50
3. Igoucheva O, Kelly A, Uitto J et al. (2008) Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3 -/- keratino-cytes in vitro. J Invest Dermatol 128:1476-86 (Pubitemid 351693189)
4. Mavilio F, Pellegrini G, Ferrari S et al. (2006) Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12:1397-402 (Pubitemid 44924498)
5. Pendaries V, Gasc G, Titeux M et al. (2010) Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa. Gene Ther 17:930-7
6. Remington J, Wang X, Hou Y et al. (2009) Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 17:26-33
7. Siprashvili Z, Nguyen NT, Bezchinsky MY et al. (2010) Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Hum Gene Ther21:1299-310
8. Titeux M, Pendaries V, Zanta-Boussif MA et al. (2010) SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 18:1509-18
9. Wagner JE, Ishida-Yamamoto A, JMcGrath JA et al. (2010) Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. New Engl J Med 363:629-3 9
10. Wong T, Gammon L, Liu L et al. (2008) Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128:2179-89
11. Woodley DT, Keene DR, Atha T et al. (2004) Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med 10:693-5 (Pubitemid 38937633)
12. Woodley DT, Remington J, Huang Y et al. (2007) Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 15:628-35
13. Woodley DT, Wang X, Amir M et al. (2013) Intravenously injected recombinant human type VII collagen homes to skin wounds and restrores skin intergrity of dystrophic epidermolysis bullosa. J Invest Dermatol 133:1910-3.